Expansile Member
20220401104 · 2022-12-22
Assignee
Inventors
- Hideo Morita (Aliso Viejo, CA, US)
- Greg Bak-Boychuk (Aliso Viejo, CA, US)
- Arnold Tuason (Aliso Viejo, CA, US)
- Matthew J. Fitz (Aliso Viejo, CA, US)
- George R. Greene, Jr. (Aliso Viejo, CA, US)
Cpc classification
A61M2025/0042
HUMAN NECESSITIES
A61B2017/12054
HUMAN NECESSITIES
A61B17/12172
HUMAN NECESSITIES
A61M2025/0096
HUMAN NECESSITIES
A61L31/14
HUMAN NECESSITIES
A61B2017/00606
HUMAN NECESSITIES
A61B2017/00575
HUMAN NECESSITIES
International classification
A61B17/12
HUMAN NECESSITIES
A61L31/14
HUMAN NECESSITIES
Abstract
An expansile member that may be used on a delivery device or may be used for occlusive purposes within the vasculature.
Claims
1. An occlusive device, comprising: a sleeve comprising a narrow portion and at least one wide portion, wherein the sleeve comprises a plurality of cells between an interior of the sleeve and an exterior surface of the sleeve; and an expansile material within the interior of sleeve; wherein in a first configuration the expansile material is unexpanded and positioned entirely within the interior of the sleeve; and, wherein in a second configuration the expansile material at least partially expands out of the plurality of cells of the sleeve.
2. The occlusive device of claim 1, wherein the at least one wide portion of the sleeve comprises a first wide portion and a second wide portion.
3. The occlusive device of claim 2, wherein the first wide portion is positioned on a first side of the narrow portion and wherein the second wide portion is positioned on a second side of the narrow portion.
4. The occlusive device of claim 1, wherein the expansile material is composed of a hydrogel.
5. The occlusive device of claim 1, wherein the sleeve comprises a hollow shell.
6. The occlusive device of claim 1, wherein the expansile material completely fills the interior of the sleeve when in the first configuration.
7. The occlusive device of claim 1, further comprising a core positioned within the interior of the sleeve, wherein the expansile material surrounds the core.
8. The occlusive device of claim 7, wherein the core is composed of a polymeric material.
9. The occlusive device of claim 7, wherein the core is composed of a metallic material.
10. The occlusive device of claim 1, wherein the expansile material sits only immediately under the exterior surface of the sleeve and forms a hollow cavity within the interior of the sleeve.
11. The occlusive device of claim 10, wherein the expansile material is bonded to an inner surface of the sleeve.
12. The occlusive device of claim 1, wherein the plurality of cells comprises a plurality of slots.
13. The occlusive device of claim 1, wherein the expansile material is expandable on contact with blood.
14. The occlusive device of claim 1, wherein the plurality of cells are located on the at least one wide portion of the sleeve.
15. An occlusive system for occluding a vascular condition, comprising: a catheter; a sleeve deliverable through the catheter, wherein the sleeve is comprised of a narrow portion and at least one wide portion, and wherein the sleeve is comprised of a plurality of cells between an interior of the sleeve and an exterior surface of the sleeve; a delivery pusher detachably connected to the sleeve for navigating the sleeve through the catheter; and an expansile material within the interior of sleeve; wherein in a first configuration the expansile material is unexpanded and positioned entirely within the interior of the sleeve; and, wherein in a second configuration the expansile material at least partially expands out of the plurality of cells of the sleeve.
16. The occlusive system of claim 15, wherein the at least one wide portion of the sleeve comprises a first wide portion and a second wide portion, and wherein the narrow portion is positioned between the first wide portion and the second wide portion.
17. The occlusive system of claim 16, wherein the vascular condition is a hole in a heart, wherein the first wide portion is positioned on a first side of the hole in the heart, and wherein the second wide portion is positioned on a second side of the hole in the heart.
18. The occlusive system of claim 15, wherein the expansile material completely fills the interior of the sleeve when in the first configuration.
19. The occlusive system of claim 15, wherein the expansile material sits only immediately under the exterior surface of the sleeve and forms a hollow cavity within the interior of the sleeve.
20. An occlusive system for occluding a vascular condition, comprising: a catheter; a sleeve deliverable through the catheter, wherein the sleeve is comprised of a narrow portion and at least one wide portion, and wherein the sleeve is comprised of a plurality of cells between an interior of the sleeve and an exterior surface of the sleeve; a delivery means for navigating the sleeve through the catheter, wherein the delivery means is detachably connected to the sleeve; and an expansile means for occluding the vascular condition, wherein in a first configuration the expansile means is unexpanded and positioned entirely within the interior of the sleeve, and wherein in a second configuration the expansile means at least partially expands out of the plurality of cells of the sleeve.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
[0011]
[0012]
[0013]
[0014]
[0015]
[0016]
[0017]
[0018]
[0019]
[0020]
[0021]
DETAILED DESCRIPTION
[0022]
[0023] The expansile member 14 is comprised of a hydrogel—an expansile, hydrophilic polymer. Hydrogels are often incorporated in embolization coils, where their expansile properties aid in space filling for applications such as aneurysm embolization. Hydrogels typically expand when exposed to material, such as blood. This response is based on the pH of the material to which the hydrogel is exposed. Thus, hydrogels utilized for intravascular procedures are designed to expand on contact with a substance having a pH within a pH range typical of blood.
[0024] Typically practitioners who regularly use liquid embolic materials encounter several problems. One problem is wash-out, which occurs when a high blood flow rate results in the liquid embolic getting washed away, especially in the opposite direction of the intended treatment site. One method of mitigating this problem is building up a dam of liquid embolic around the tip of the microcatheter. The inclusion of the expansile member 14 will eliminate the need for this dam since the expansile member 14 will fill the space between the microcatheter 10 and the vessel wall, thus preventing wash-out of the embolic and in effect acting as a dam.
[0025] Another problem is reflux of the embolic. As the clinician attempts to fill the treatment area (located distal of the distal tip of the delivery device), embolic may start to reflux proximally toward the distal tip of the catheter, especially as there is less resistance in this direction. Reflux may cause the catheter to get stuck to the embolic mass, in effect getting ‘glued’ into place. The expansile member 14 prevents reflux by filling the space around the distal tip of the delivery device thus blocking backflow.
[0026]
[0027] Though only three are shown in these figures, namely ovular, frustoconical and cylindrical, respectively, it is to be understood that the expansile member 14 may assume a great variety of other shapes, including but not limited to circular, rectangular, non-symmetrical, polygonal, cubical, etc. Thus, the shapes shown are just examples of the various shapes said expansile member can assume. Each of the members 14 has a proximal end or portion 13 and a distal end or portion 15. The embodiments incorporating an unconstrained shape having increasing diameters, such as the frustocone of
[0028] Regardless of the unconstrained shape of the expansile member, it is desirable for the distal portion 13 of member 14 to expand to fill or substantially fill the gap between the delivery device and the wall of the vessel through which the delivery device is delivered. In the case where the microcatheter is used to deliver liquid embolic, the embolic is preferably delivered from the distal end of the microcatheter. The hydrogel may be configured to expand to its full diameter within 15-25 minutes, which should be sufficient time to advance the microcatheter to the target site based upon current clinical practices.
[0029] In a typical embolic procedure, a guide catheter is used to navigate a first portion of the vasculature. A guidewire is then used to navigate the remaining portion to the particular target location within the vasculature, and, finally, a microcatheter is delivered over this guidewire. The guidewire is subsequently withdrawn. Once the microcatheter is in place, liquid (or other) embolic is delivered through the microcatheter to treat the target site. Thus, the total microcatheter diameter (which includes the unexpanded expansile member mounted to a portion of the microcatheter) must be smaller than the inner diameter of the guide catheter in order to navigate through said guide catheter.
[0030] A retaining member is used to secure the expansile member 14 to the delivery device 10. In one example the retaining member is a coil 12 placed over the expansile member 14. Various coil properties can affect the expansile member 14. For example, a tightly wound coil or one with minimal gap length between windings will limit the amount of hydrogel that expands through the coil upon exposure to blood. A loosely wound coil or one with significant gap length between windings will allow more hydrogel expansion through said windings.
[0031] Various sizes can be used for all the elements (delivery device 10, expansile member 14, coil 12). One example configuration is as follows: the delivery device 10 is a microcatheter which has a 0.013″ inner diameter and 0.021″ outer diameter. The de-hydrated (pre-expanded) expansile member 14 has an inner diameter of 0.021″ and a maximum outer diameter of 0.029′ and is 0.09″ long. The retaining member is a straight helical over-coil 12 with an inner diameter of 0.036″, made from a 0.001″ filar, and is 0.130″ long. Note the expansile member 14 sits over the microcatheter 10, thus the inner diameter of the expansile member 14 matches the outer diameter of the microcatheter 10. The coil 12 is positioned over the expansile member 14 and both ends are pinched down onto the microcatheter body 10 with a coining tool, or via hand crimping. The pinched ends of the over-coil 12 may be secured to the microcatheter 10 via UV adhesive. The expansile member 14 may be secured to the microcatheter 10 with a UV adhesive and further restrained by the over-coil 12. In one example the over-coil 12 may be tensioned such that it sits into the unexpanded expansile member 14. In another example the over-coil 12 sits over or at the periphery of the unexpanded expansile member 14. The microcatheter 10 may be provided sterile with the incorporated ring and over-coil, and may include a hydrophilic coating to reduce friction when navigating the vasculature. In one example the expansile member 14 is not coated with a hydrophilic coating, said coating could delay expansion of the expansile member 14.
[0032]
[0033] Retention sleeve 16 can be secured to the delivery device 10 (i.e. microcatheter) shaft by adhesive bonding, thermal fusion, or via mechanical means (i.e. retaining rings and/or marker bands).
[0034]
[0035] The occlusive device 20 is delivered via a delivery device 10 (i.e. microcatheter) and can be connected to a pusher 21 with a detachment zone 22 which can be degraded or severed to detach the occlusive device 20 from pusher 21. Depending on the properties of sleeve 16 (i.e. restraining strength or thickness), the sleeve 16 may initially bulge out a bit when the expansile member starts to expand upon contact with blood, before the expansile member protrudes from cells 18. This bulging should not affect the overall shape of the occlusive device, as the occlusive device should have an undulating profile so the middle of the device bridges the hole while the proximal and distal bulged ends of the device 20 fill the space on either side of the hole.
[0036]
[0037] Depending on the properties of sleeve 16 (i.e. restraining strength or thickness), the sleeve may initially bulge out a bit when the expansile member starts to expand upon contact with blood, before the expansile member protrudes from cells 18. Device 30 is delivered via a pusher 21 and is delivered through a delivery device 10 (i.e. microcatheter). The pusher may contain a severable detachment zone linkage to sever the pusher from occlusive device 30.
[0038] The embodiments described in
[0039] Although the invention has been described in terms of particular embodiments and applications, one of ordinary skill in the art, in light of this teaching, can generate additional embodiments and modifications without departing from the spirit of or exceeding the scope of the claimed invention. Accordingly, it is to be understood that the drawings and descriptions herein are proffered by way of example to facilitate comprehension of the invention and should not be construed to limit the scope thereof.